🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
This multicentre, randomized controlled trial evaluates the effect and safe...
Status
Recruiting
Location
Guangdong Provincial Hospital of Chinese Medicine
Start Date
2026-01-15
Trial ID
NCT07337096
Treatments Being Tested
This phase I trial studies the side effects and how well surgery and heated...
Status
Active Not Recruiting
Location
City of Hope Corona
Start Date
2014-05-19
Trial ID
NCT01970722
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2015-01-01
Trial ID
NCT06711055
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested